|
|
News Breaks
|
November 17, 2009
|
| 07:12 EDT |  | CYCC |
| theflyonthewall.com: | Cyclacel Pharmaceuticals to present Sapacitabine Phase 2 AML MDS data | | Cyclacel Pharmaceuticals announced today that updated Phase 2 clinical trial results of sapacitabine for the treatment of advanced myeloid leukemia, AML, and myelodysplastic syndromes MDS, will be presented at two poster presentations during the 51st Annual Meeting of the American Society of Hematology in New Orleans, LA, on Saturday, December 5. :theflyonthewall.com |
|
|
News For CYCC From The Last 14 Days Check below for free stories on CYCC the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 8, 2012
|
| 07:42 EDT |  | CYCC |
| theflyonthewall.com: | Cyclacel Pharmaceuticals management to meet with Lazard Capital | | Meeting to be held in Boston on February 10 hosted by Lazard Capital. :theflyonthewall.com |
|
|
|
|
|
